Dr. Norhan Bader is a co-founder and vice chair of Women in Global Health, Egypt chapter, promoting women leaders in global health. Norhan is a physician by training who graduated from Cairo University with extensive experience in the field of sexual and reproductive health and rights, or SRHR, for more than 10 years. She is the SRHR program manager at the Center for Development Services.

Dr. Othoman Mellouk is the intellectual property and access to medicines/diagnostics lead at the International Treatment Preparedness Coalition. Othoman previously worked at Association de Lutte Contre le Sida in Morocco, where he participated in the development of the first prevention program targeting men having sex with men in the Middle East and North Africa. He is one of the most active advocates for access to treatment in the MENA region with a particular focus on the question of intellectual property rights and their effect on access to treatment. He has also served at WHO’s Strategic and Technical Advisory Committee on HIV.

Dr. Otto Chabikuli is FHI 360’s vice president of the eastern and southern Africa region, where he oversees work focused on health, civil society strengthening, livelihoods and economic strengthening, education, environment, research, and youth development. Chabikuli is a family physician and health systems and policy analyst.

Dr. Otto Nzapfurundi Chabikuli leads the eastern and southern Africa regional office at FHI 360, a global health and human development nonprofit working in more than 60 countries. Born in the Democratic Republic of Congo, Chabikuli obtained his medical degree and a master’s degree in family medicine from the Medical University of Southern Africa, and a Master of Sciences in Health Systems Management from the London School of Hygiene and Tropical Medicine.

Dr. Pamela Cipriano is an internationally recognized nursing leader. As the UHC2030 co-chair, she has been instrumental in shaping policies that promote quality and affordable health care services. She is the International Council of Nurses president and University of Virginia professor and previously served as the UVA School of Nursing dean and American Nurses Association president.

Dr. Patrick L. Osewe is the chief of the health sector group at the Asian Development Bank. He is responsible for leading the application of evidence-based and innovative approaches to address priority and emerging health issues in Asia and the Pacific, including the organization’s comprehensive COVID-19 preparedness and response activities.

Dr. Paul Sonenthal is a pulmonary and critical care physician at Brigham and Women’s Hospital, instructor at Harvard Medical School, and director of inpatient medicine and critical care at Partners In Health, where he leads strategic design, implementation, and evaluation of critical care medicine programs. An internationally recognized leader in global critical care and oxygen ecosystems, he is the principal investigator of the Unitaid-funded project BRING O2, which is accelerating access to safe, reliable, and quality medical oxygen in Malawi, Rwanda, Peru, Lesotho, and Madagascar.

Dr. Petra Khoury is the director of health and care at IFRC. She leads the International Federation of Red Cross and Red Crescent Societies’ work on health security, health protection, and WASH. Prior to IFRC, she was the senior health adviser to the prime minister of Lebanon and led the national COVID-19 response plan and chaired the national COVID-19 Vaccination Executive Committee. Petra holds a doctorate in pharmacy. She completed her residency at Massachusetts General Hospital.

Dr. Phil Febbo was appointed as Illumina’s chief medical officer in March 2018 and is responsible for developing and executing the company’s medical strategy to drive genomic testing into health care practice. Dr. Febbo has a successful track record of translational research, clinical excellence, and embedding molecular insights into clinical care. Before Illumina, Dr. Febbo served as CMO of Genomic Health for five years. Prior to that, Dr. Febbo was a professor of Medicine and Urology at the University of California, San Francisco (UCSF), where his laboratory focused on using genomics to understand the biology and clinical behavior of prostate cancer.

Dr. Philippe Duneton has more than 25 years’ experience in the fields of HIV/AIDS, infectious and tropical diseases and public health. As Unitaid’s executive director, he has led the organization’s response to the COVID-19 pandemic, playing a vital role as the co-lead of the therapeutics arm of the Access to COVID Tools Accelerator. Previously, he was a practicing doctor at La Pitié Salpêtrière Hospital in Paris (infections diseases department) and was twice adviser to the French Ministry of Health under Minister Bernard Kouchner.